Beyond lifelong physical conditions, cancer survivorship can bring long-term mental health concerns, such as anxiety, depression and isolation. In an effort to support cancer survivors, researchers from Drexel University are exploring music therapy as a way to better understand what they're going through and help them…
Назван продукт, вещество из которого способно замедлить развитие рака груди Поиск - новости науки и техники
В Казахстане расширили диагностику рака: ПЭТ/КТ выросла на 21,6%, скрининги до 41,7% Талдыкорган Инфо
Профилактика ВПЧ: Два десятилетия научных исследований показывают, что она снижает бремя болезней и рака. Vietnam.vn
В онкоцентре Челябинска рассказали, какие опухоли можно найти с помощью УЗИ 1obl.
В Новосибирской области создано экологическое движение против рака КПРФ в Новосибирске
В Казахстане расширяют раннюю диагностику рака » Новости из самого сердца Алтая свежие на сегодня ALTAINEWS
В Казахстане расширяется ранняя диагностика рака Служба центральных коммуникаций при Президенте РК
People who reach 110 and beyond appear to have unusually large numbers of rare immune cells capable of killing abnormal cells. These CD4 cytotoxic T cells became more common with age and often expanded into large groups of nearly identical cells, suggesting the immune system was repeatedly responding to persistent…
Двигатель для китайской многоразовой ракеты «Синъюнь-2» прошёл огневой тест hightech.plus
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes CancerNetwork
New research from UTHealth Houston found firefighters experience measurable biological changes in their blood and urine within 24 hours of fighting a fire—changes that may help identify early cancer risk, the leading cause of death among firefighters.
A new Northwestern Medicine study has identified a previously unknown mechanism by which an enzyme promotes cancer cell proliferation, establishing it as a promising therapeutic target for cancer, according to findings published in Nature Communications.
Researchers in Purdue University's College of Pharmacy have developed and validated a new series of small-molecule inhibitors that promote antitumor immunity and hold promise as anticancer agents.
